Advertisement

Ligase IV Syndrome

  • Dimitry A. Chistiakov
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 685)

Abstract

Ligase IV (LIG4) syndrome belongs to the group of hereditary disorders associated with impaired DNA damage response mechanisms. Clinically and morphologically, patients affected with this syndrome are characterized by microcephaly, unusual facial features, growth retardation, developmental delay, skin anomalies and are typically pancytopenic. The disease leads to acute radiosensitivity, immunodeficiency and bone marrow abnormalities. LIG4 syndrome arises from hypomorphic mutations in the LIG4 gene encoding DNA ligase IV; a component of the nonhomologous end-joining machinery, which represents a major mechanism of repair of double strand DNA breaks in mammals. The hypomorphic mutations do not completely abolish but significantly reduce enzyme function. This results in impaired V(D)J recombination, the essential rejoining process in T- and B-cell development, in whose ligase IV plays the key role. As a consequence, patients with LIG4 syndrome frequently develop multiple immune abnormalities, clinically overlapping with severe combined immunodeficiency sy

Keywords

Nijmegen Breakage Syndrome BRCT Domain Hypomorphic Mutation Bone Marrow Abnormality Omenn Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    O’Driscoll M, Gennery AR, Seidel J et al. An overview of three new disorders associated with genetic instability: LIG4 syndrome, RS-SCID and ATR-Seckel syndrome. DNA Repair (Amsterdam) 2004; 3:1227–1235.CrossRefGoogle Scholar
  2. 2.
    Revy P, Buck D, le Deist F et al. The repair of DNA damages/modifications during the maturation of the immune system lessons from human primary immunodeficiency disorders and animal models. Adv Immunol 2005; 87:237–295.CrossRefPubMedGoogle Scholar
  3. 3.
    O’Driscoll M, Cerosaletti KM, Girard P et al. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001; 8:1175–1185.CrossRefPubMedGoogle Scholar
  4. 4.
    Winter RM, Baraitser M. The London Dysmorphology Database. Great Britain: Oxford University Press, 2003.Google Scholar
  5. 5.
    Ben-Omran TI, Cerosaletti K, Conacannon P et al. A patient with mutations in DNA ligase IV: clinical features and overlap with Nijmegen Breakage Syndrome. Am J Med Genet 2005; 137A:283–287.CrossRefPubMedGoogle Scholar
  6. 6.
    Helleday T, Lo J, van Gent DC et al. DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair (Amsterdam) 2007; 6:923–935.CrossRefGoogle Scholar
  7. 7.
    Lieber MR, Ma Y, Pannicke U et al. The mechanism of vertebrate nonhomologous DNA end joining and its role in V(D)J recombination. DNA Repair (Amsterdam) 2004; 3:817–826.CrossRefGoogle Scholar
  8. 8.
    Chan DW, Chen BP, Prithivirajsingh S et al. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev 2002; 16:2333–2338.CrossRefPubMedGoogle Scholar
  9. 9.
    Ma Y, Pannicke U, Schwarz K et al. Hairpin opening and overhang processing by an Artemis:DNA-PKcs complex in V(D)J recombination and in nonhomologous end joining. Cell 2002; 108:781–794.CrossRefPubMedGoogle Scholar
  10. 10.
    Kysela B, Doherty AJ, Chovanec M et al. Ku stimulation of DNA ligase IV-dependent ligation requires inward movement along the DNA molecule. J Biol Chem 2003; 278:22466–22474.CrossRefPubMedGoogle Scholar
  11. 11.
    Wei Y-F, Robins P, Carter K et al. Molecular cloning and expression of human cDNAs encoding a novel DNA ligase IV and DNA ligase III, an enzyme active in DNA repair and recombination. Mol Cell Biol 1995; 15:3206–3216.PubMedGoogle Scholar
  12. 12.
    Robins P, Lindahl T. DNA ligase IV from HeLa cell nuclei. J Biol Chem 1996; 271:24257–24261.CrossRefPubMedGoogle Scholar
  13. 13.
    Sibanda BL, Critchlow SE, Begun J et al. Crystal structure of an Xrcc4-DNA ligase IV complex. Nat Struct Biol 2001; 8:1015–1019.CrossRefPubMedGoogle Scholar
  14. 14.
    Doherty AJ, Suh SW. Structural and mechanistic conservation in DNA ligases. Nucleic Acids Res 2000; 28:4051–4058.CrossRefPubMedGoogle Scholar
  15. 15.
    Pascal JM, O’Brien PJ, Tomkinson AE et al. Human DNA ligase I completely encircles and partially unwinds nicked DNA. Nature 2004; 432:473–478.CrossRefPubMedGoogle Scholar
  16. 16.
    Lee YE, Chang C, Song HK et al. Crystal structure of NAD(+)-dependent DNA ligase: modular architecture and functional implications. EMBO J 2000; 19:1119–1129.CrossRefPubMedGoogle Scholar
  17. 17.
    Subramanya HS, Doherty AJ, Ashford SR et al. Crystal structure of an ATP-dependent DNA ligase from bacteriophage T7. Cell 1996; 85:607–615.CrossRefPubMedGoogle Scholar
  18. 18.
    Hakansson K, Doherty AJ, Shuman S et al. X-ray crystallography reveals a large conformational change during guanyl transfer by mRNA capping enzymes. Cell 1997; 89:545–553.CrossRefPubMedGoogle Scholar
  19. 19.
    Marchetti C, Walker SA, Odreman F et al. Identification of a novel motif in DNA ligases exemplified by DNA ligase IV. DNA Repair (Amsterdam) 2006; 5:788–798.CrossRefGoogle Scholar
  20. 20.
    Frank KM, Sekiguchi JM, Seidl KJ et al. Late embryonic lethality and impaired V(D)J recombination in mice lacking DNA ligase IV. Nature 1998; 396:173–177.CrossRefPubMedGoogle Scholar
  21. 21.
    Mills KD, Ferguson DO, Essers J et al. Rad54 and DNA ligase IV cooperate to maintain mammalian chromatid stability. Genes Dev 2004; 18:1283–1292.CrossRefPubMedGoogle Scholar
  22. 22.
    Frappart PO, Lee Y, Russell HR et al. Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency. Proc Natl Acad Sci USA (in press). Doi: 10.1073/ pnas.0806882106.Google Scholar
  23. 23.
    Adachi N, Ishino T, Ishii Y et al. DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: Implications for DNA double-strand break repair. Proc Natl Acad Sci USA 2001; 98:12109–13.CrossRefPubMedGoogle Scholar
  24. 24.
    Sharpless NE, Ferguson DO, O’Hagan RC et al. Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations, amplifications and deletions. Mol Cell 2001; 8:1187–1196.CrossRefPubMedGoogle Scholar
  25. 25.
    Sado K, Ayusawa D, Enomoto A et al. Identification of a mutated DNA ligase IV gene in the X-ray-hypersensitive mutant SX10 of mouse FM3A cells. J Biol Chem 2001; 276:9742–9748.CrossRefPubMedGoogle Scholar
  26. 26.
    Nijnik A, Woodbine L, Marchetti C et al. DNA repair is limiting for haematopoietic stem cells during ageing. Nature 2007; 447:686–690.CrossRefPubMedGoogle Scholar
  27. 27.
    Riballo E, Critchlow SE, Teo S-H et al. Identification of a defect in DNA ligase IV in a radiosensitive leukaemia patient. Curr Biol 1999; 9:699–702.CrossRefPubMedGoogle Scholar
  28. 28.
    Riballo E, Doherty AJ, Dai Y et al. Cellular and biochemical impact of a mutation in DNA ligase IV conferring clinical radiosensitivity. J Biol Chem 2001 276; 33:31124–31132.CrossRefPubMedGoogle Scholar
  29. 29.
    Badie C, Goodhardt M, Waugh A et al. A DNA double-strand break defective fibroblast cell line, (180BR), derived from a radiosensitive patient represents a new mutant phenotype. Cancer Res 1997; 57:4600–4607.PubMedGoogle Scholar
  30. 30.
    Toita N, Hatano N, Ono S et al. Epstein—Barr virus-associated B-cell lymphoma in a patient with DNA ligase IV (LIG4) syndrome. Am J Med Genet A 2007; 143A:742–745.CrossRefGoogle Scholar
  31. 31.
    Buck D, Moshous D, de Chasseval R et al. Severe combined immunodeficiency and microcephaly in siblings with hypomorphic mutations in DNA ligase IV. Eur J Immunol 2006; 36:224–235.CrossRefPubMedGoogle Scholar
  32. 32.
    Girard P-M, Kysela B, Harer CJ et al. Analysis of DNA ligase IV mutations found in LIG4 syndrome patients: the impact of two linked polymorphisms. Hum Mol Genet 2004; 13:2369–2376.CrossRefPubMedGoogle Scholar
  33. 33.
    Grawunder U, Zimmer D, Lieber MR. DNA ligase IV binds to XRCC4 via a motif located between rather than within its BRCT domains. Curr Biol 1998; 8:873–876.CrossRefPubMedGoogle Scholar
  34. 34.
    Gruhn B, Seidel J, Zintl F et al. Successful bone marrow transplantation in a patient with DNA ligase IV deficiency and bone marrow failure. Orphanet J Rare Dis 2007; 2:5.CrossRefPubMedGoogle Scholar
  35. 35.
    Roddam PL, Rollinson S, O’Driscoll M et al. Genetic variants of NHEJ DNA ligase IV can affect the risk of developing multiple myeloma, a tumour characterised by aberrant class-switch recombination. J Med Genet 2002; 39:900–905.CrossRefPubMedGoogle Scholar
  36. 36.
    Fenton JAL, Pratt G, Rawstron AC et al. Isotype class switching and the pathogenesis of multiple myeloma. Hematolog Oncol 2002; 19:1–12.CrossRefGoogle Scholar
  37. 37.
    Van der Burg M, van Veelen LR et al. A new type of radiosensitive T-B-NK+ severe combined immunodeficiency caused by a LIG4 mutation. J Clin Invest 2006; 116:137–145.CrossRefPubMedGoogle Scholar
  38. 38.
    Grunebaum E, Bates A, Roifman CM. Omenn syndrome is associated with mutations in DNA ligase IV. Allergy Clinical Immunology 2008; 122:1219–1220.CrossRefGoogle Scholar
  39. 39.
    Enders A, Fisch P, Schwarz K et al. A severe form of human combined immunodeficiency due to mutations in DNA ligase IV. J Immunol 2006; 176:5060–5068.PubMedGoogle Scholar
  40. 40.
    Moshous D, Pannetier C, Chasseval RR et al. Partial T-and B-lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis. J Clin Invest 2003; 111:381–387.PubMedGoogle Scholar
  41. 41.
    Ege M, Ma Y, Manfras B et al. Omenn syndrome due to ARTEMIS mutations. Blood 2005; 105:4179–4186.CrossRefPubMedGoogle Scholar
  42. 42.
    Neitzel H, Jeggo PA, Concannon P. DNA ligase IV mutations identified in patients exhibiting developmental delay and immunodeficiency. Mol Cell 2001; 8:1175–1185.CrossRefPubMedGoogle Scholar
  43. 43.
    Noordzij JG, Verkaik NS, van der Burg M et al. Radiosensitive SCID patients with Artemis gene mutations show a complete B-cell differentiation arrest at the preB-cell receptor checkpoint in bone marrow. Blood 2003; 101:1446–1452.CrossRefPubMedGoogle Scholar

Copyright information

© Landes Bioscience and Springer Science+Business Media 2010

Authors and Affiliations

  • Dimitry A. Chistiakov
    • 1
  1. 1.Department of Molecular DiagnosticsNational Research Center GosNIIGenetikaMoscowRussia

Personalised recommendations